Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Artiva Biotherapeutics (ARTV) Prepaid Assets (2023 - 2025)

Artiva Biotherapeutics (ARTV) has disclosed Prepaid Assets for 3 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 50.18% year-over-year to $4.6 million; the TTM value through Dec 2025 reached $4.6 million, up 50.18%, while the annual FY2025 figure was $4.6 million, 50.18% up from the prior year.
  • Prepaid Assets hit $4.6 million in Q4 2025 for Artiva Biotherapeutics, down from $6.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $6.7 million in Q2 2025 and bottomed at $1.1 million in Q4 2023.
  • Average Prepaid Assets over 3 years is $3.8 million, with a median of $3.5 million recorded in 2024.
  • On a YoY basis, Prepaid Assets climbed as much as 285.16% in 2025 and fell as far as 50.18% in 2025.
  • Artiva Biotherapeutics' Prepaid Assets stood at $1.1 million in 2023, then surged by 179.95% to $3.1 million in 2024, then soared by 50.18% to $4.6 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $4.6 million, $6.5 million, and $6.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.